 BORDENTOWN, N.J., March 01, 2021 GLOBE NEWSWIRE -- Caelum Biosciences, Inc. Caelum, a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases, today announced its collaboration with and support of the amyloidosis advocacy community as Amyloidosis Awareness Month begins. The campaign was created to spread awareness about this rare disease and its symptoms to help prompt earlier diagnosis for patients. 